SMTL ID : 4f09.1

Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x JAK: 2-methyl-1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine(Non-covalent)

JAK.1: 13 residues within 4Å: Chain A: L.25, G.26, V.33, A.50, V.81, M.99, E.100, Y.101, L.102, G.105, R.150, L.153, G.163 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:L.153, A:L.153 Hydrogen bonds: A:E.100, A:L.102 Water bridges: A:N.151, A:D.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zak, M. et al., Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2. J.Med.Chem. (2012)

Release Date

2012-07-04

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence